SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (5241)2/2/1998 8:23:00 PM
From: DR. BOND  Read Replies (2) of 23519
 
Script Data Week ending 1/25 (which includes MLK Day)

New 9,328 down 1%
Refills 4,416 down 4.5%
Total 13,744 down 2.2%

Partial explanation for slight decrease could be product being diverted to UK market!

As for an update on Friday's open house, I will not have a complete report till earliest Tues night.

Some initial comments were as follows:

1. New facility is "very impressive" with 1 line running, 3 more being completed with total capacity of 8 lines.

2. New facility will allow VVUS to manufacture MUSE at a far lower cost per unit. These economies of scale will probably lead to "EARNINGS INCREASES" once the new facility is approved!

3. VVUS mgmt has indicated very confidently that MCA approval is "ON TRACT" for APPROVAL early March. (IMO this could occur as early as late Feb.)!

4. Several analysts from MAJOR WALL ST. FIRMS were in attendance and new coverage is not unlikely.

5. One analyst in particular will probably "UPGRADE THE STOCK" very soon.

6. VVUS is producing MUSE "at risk" at the new facility!!

More to follow tomorrow,

DB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext